|
kEUR |
H1 2023 |
H1 2022 |
|
|
|
|
|
Operating result (EBIT) |
-34,464 |
15,482 |
|
Depreciation, amortization and impairment charges (if any) |
15,077 |
11,224 |
|
EBITDA |
-19,387 |
26,706 |
|
kEUR |
H1 2023 |
H1 2022 |
|
|
|
|
|
Last twelve months Operating result (EBIT) |
-37,340 |
48,844 |
|
Average 1 Net operating assets: |
|
|
|
Total non-current assets (average) |
311,538 |
254,607 |
|
Total current assets (average) |
272,649 |
320,994 |
|
Cash and cash equivalents (average) |
-37,711 |
-126,899 |
|
Total current liabilities (average) |
-119,822 |
-106,084 |
|
Average 1 Net operating assets |
426,654 |
342,618 |
|
Return on net operating assets (RONOA) |
-8.8% |
14.3% |
1 The average amounts are calculated as: (Current period's figures + prior period's figures) / 2.
|
kEUR |
H1 2023 |
H1 2022 |
|
|
|
|
|
Net cash flows from operating activities |
-48,322 |
-7,659 |
|
Acquisition of intangible assets |
-2,277 |
-2,146 |
|
Acquisition of property, plant and equipment |
-29,089 |
-39,080 |
|
Free Cash Flow |
-79,688 |
-48,885 |
|
kEUR |
As at 30 June 2023 |
As at 31 December 2022 |
|
|
|
|
|
Cash and cash equivalents |
8,985 |
37,528 |
|
Interest-bearing liabilities (Total financial debt): |
|
|
|
Lease liabilities (Non-current) |
-19,505 |
-17,652 |
|
Other financial liabilities (Non-current) |
-9,602 |
-9,410 |
|
Interest-bearing loans and borrowings (Current) |
-55,172 |
0 |
|
Lease liabilities (Current) |
-3,326 |
-3,566 |
|
Other financial liabilities (Current) |
-1,153 |
-1,096 |
|
Interest-bearing liabilities (Total financial debt) |
-88,758 |
-31,724 |
|
Net Cash / (debt) |
-79,773 |
5,804 |
|
kEUR |
H1 2023 |
H1 2022 |
|
|
|
|
|
Revenue at constant currencies 1 |
134,430 |
130,683 |
|
Impact from changes in exchange rates compared to prior period |
-2,596 |
2,973 |
|
Revenue reported (IFRS) |
131,834 |
133,656 |
1 Revenue translated into the presentation currency, EUR, using the weighted average EUR currency exchange rate from the prior period.
|
|
H1 2023 vs H1 2022 |
H1 2022 vs H1 2021 |
|
|
|
|
|
Change in revenue reported (IFRS) (%) |
-1.4% |
-1.1% |
|
Change in revenue at constant currencies (%) |
2.9% |
-3.3% |
|
kEUR |
H1 2023 |
H1 2022 |
|
|
|
|
|
Revenue associated with the coronavirus pandemic |
1,507 |
32,823 |
|
Revenue not associated with the coronavirus pandemic |
130,327 |
100,833 |
|
Revenue reported (IFRS) |
131,834 |
133,656 |
|
|
|
|
|
kEUR |
H1 2023 |
H1 2022 |
|
|
|
|
|
Revenue not associated with the coronavirus pandemic |
130,327 |
100,833 |
|
Custom Projects |
58,037 |
46,839 |
|
Contract Manufacturing |
56,686 |
41,349 |
|
Generics & Cosmetics |
15,604 |
12,645 |
|
|
|
|
|
kEUR |
H1 2023 |
H1 2022 |
|
|
|
|
|
Property, plant and equipment assets capitalized |
17,690 |
36,432 |
|
Intangible assets capitalized |
1,656 |
1,494 |
|
Capital expenditures (Capex) |
19,346 |
37,926 |